Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of BDP Nasal Aerosol in Pediatric PAR
NCT01783548Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in perennial allergic rhinitis (PAR), sponsored by Teva Pharmaceutical Industries Ltd.. Started Jan 2013; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01783548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783548.